Accretion Pharmaceuticals IPO is scheduled to open on May 14, 2025, and will close on May 16, 2025. This book-built issue is worth ₹29.75 crores and includes only a fresh issue of 29.46 lakh shares. The IPO price band is fixed between ₹96 to ₹101 per share.
The minimum lot size is 1,200 shares, making the minimum investment for retail investors around ₹1,15,200, but it is advised to apply at the cutoff price, which comes to approximately ₹1,21,200, to improve chances in case of oversubscription.
For HNI investors, the minimum investment is 2 lots (2,400 shares), amounting to ₹2,42,400. The allotment date is expected on May 19, 2025, and the listing is likely to take place on the NSE SME platform on May 21, 2025.
Accretion Pharmaceuticals Limited, started in 2012, is a pharma company based in Sanand, Ahmedabad, Gujarat. It makes and sells a wide range of healthcare products like tablets, capsules, syrups, creams, ointments, and powders. The company also provides contract manufacturing services.
Their product range includes antibiotics, pain relief, heart and stomach medicines, as well as ayurvedic and herbal products. Accretion is ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certified, showing its commitment to quality and safety. The company exports to over 20 countries, especially in Africa, Southeast Asia, and the Middle East. As of January 2025, it has 83 employees, including 4 executive directors. Strong promoter experience, good customer relations, and a focus on quality give the company a competitive edge.
Overview of Contents
Accretion Pharmaceuticals IPO Overview
| IPO Name | Accretion Pharmaceuticals |
|---|---|
| Exchange to List On | NSE SME Platform |
| Face Value per Share | ₹10 |
| Price Band | ₹96 to ₹101 per equity share |
| Minimum Investment (Retail) | ₹1,15,200 for 1 lot (1,200 shares) |
| Lot Size | 1,200 shares |
| IPO Type | Book Building Issue |
| Pre-Issue Equity Shares | 81,70,000 shares |
| Post-Issue Equity Shares | 1,11,16,000 shares |
| Total Issue Size | 29,46,000 shares (₹29.75 Cr approx.) |
| Fresh Issue Only | Yes (Full issue is fresh equity) |
| Market Maker Reservation | 1,47,600 shares |
| QIB Quota | Up to 50% of net issue |
| Retail Investor Quota | At least 35% of net issue |
| HNI/NII Quota | Up to 15% of net issue |
Accretion Pharmaceuticals IPO Prospectus
| DRHP | Click here |
| RHP | Click here |
Accretion Pharmaceuticals IPO Dates
| Event | Date |
|---|---|
| IPO Opening Date | 14 May 2025 (Wednesday) |
| IPO Closing Date | 16 May 2025 (Friday) |
| UPI Mandate Confirmation Deadline | 16 May 2025, 5:00 PM |
| Basis of Allotment (Tentative) | 19 May 2025 (Monday) |
| Initiation of Refunds | 20 May 2025 (Tuesday) |
| Credit of Shares to Demat Account | 20 May 2025 (Tuesday) |
| Listing Date (Tentative) | 21 May 2025 (Wednesday) |
Accretion Pharmaceuticals IPO Lot Size
Retail and HNI investors can apply for a minimum of 1 lot (1,200 shares) and in multiples thereafter. The table below shows the minimum and maximum investment limits for both categories:
| Investor Type | No. of Lots | Total Shares | Investment Amount |
|---|---|---|---|
| Retail (Min & Max) | 1 Lot | 1,200 Shares | ₹1,21,200 |
| HNI (Minimum) | 2 Lots | 2,400 Shares | ₹2,42,400 |
Accretion Pharmaceuticals IPO Promoter Holding
Accretion Pharmaceuticals Limited is led by its promoters Mr. Mayur Popatlal Sojitra, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, and Mr. Hardik Mukundbhai Prajapati. The following table shows their shareholding before and after the IPO.
| Stage | Promoter Holding |
|---|---|
| Pre-Issue Holding | 100.00% |
| Post-Issue Holding | [To be updated] |
Accretion Pharmaceuticals Financial Performance
| Financial Metrics | Sep 30, 2024 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|
| Total Assets | 29.34 | 27.05 | 20.58 | 17.74 |
| Operating Revenue | 11.89 | 33.94 | 29.53 | 22.58 |
| Profit After Tax (PAT) | 1.57 | 3.88 | 0.10 | 0.08 |
| Shareholders’ Equity | 9.91 | 5.35 | 3.84 | 3.08 |
| Reserves & Surplus | 1.74 | 1.35 | - | - |
Accretion Pharmaceuticals IPO – Key Valuation Indicators
| Metric | Value |
|---|---|
| Return on Equity (ROE) | 25.20% |
| Return on Capital Employed (ROCE) | 11.73% |
| Debt to Equity Ratio | 2.52 |
| Return on Net Worth (RoNW) | 72.47% |
| Profit After Tax Margin (PAT Margin) | 11.51% |
| Price to Book Value (P/BV) | Data Not Provided |
- Capital expenditure for purchase of new equipment and machinery
- Capital expenditure for upgradation of existing manufacturing facility
- Repayment/prepayment of certain borrowings
- Funding working capital requirements
- General corporate purposes
Accretion Pharmaceuticals IPO Review
- Swastika Investmart –
- Ventura Securities –
- Geojit –
- Reliance Securities –
- Capital Market –
- BP Wealth –
- ICICIdirect –
- Choice Broking –
- Canara Bank –
- DRChoksey FinServ –
- Emkay Global –
- Hem Securities –
- IDBI Capital –
- Marwadi Shares –
- Nirmal Bang –
- SBICAP Securities –
- Sharekhan –
- SMC Global –
- Sushil Finance –
Accretion Pharmaceuticals IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/
IPO Lead Managers aka Merchant Bankers
- Jawa Capital Services Private Limited
Company Address
- Accretion Pharmaceuticals Limited
- 29 Xcelon Ind Park 1,
- B/h, Intas Pharmaceuticals, Vasna Chacharvad
- Sanand,
- Phone: +91-97148 82929
- Email: [email protected]
- Website: https://accretionpharma.com/
Accretion Pharmaceuticals IPO FAQs
When does the Accretion Pharmaceuticals IPO open for subscription?
The IPO opens on May 14, 2025 and closes on May 16, 2025.
What is the price band for Accretion Pharmaceuticals IPO?
The price band is set between ₹96 to ₹101 per share.
What is the minimum lot size for retail investors?
Retail investors can apply for a minimum of 1 lot (1,200 shares), requiring an investment of ₹1,21,200 at the upper price band.
When will the allotment for Accretion Pharmaceuticals IPO be finalized?
The allotment is expected to be finalized on May 19, 2025.
What is the tentative listing date for the Accretion Pharmaceuticals IPO?
The IPO is expected to be listed on NSE SME on May 21, 2025.
Where will Accretion Pharmaceuticals shares be listed?
Shares will be listed on the NSE SME platform.
What is the total issue size of Accretion Pharmaceuticals IPO?
The IPO consists of a fresh issue of 29.46 lakh shares, aggregating up to ₹29.75 crore.
Who are the promoters of Accretion Pharmaceuticals Limited?
The promoters are Mr. Mayur Popatlal Sojitra, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, and Mr. Hardik Mukundbhai Prajapati.